Skip to main content
. 2020 Mar 5;25(6):1187–1194. doi: 10.1007/s10147-020-01639-4

Table 3.

Multivariable analysis for post-treatment wish for parenthood and univariable analysis for fulfillment of desired parenthood

Wish for post-treatment parenthood Fulfillment of parenthood
Odds ratio 95% CI Odds ratio 95% CI
Female sex 0.69 0.45–1.05 0.82 0.42–1.62
Agea 0.60 0.52–0.69 0.92 0.72–1.18
Calendar year of diagnosisa 1.97 0.16–23.60 0.75 0.60–0.95
Time interval since last treatmenta 2.12 0.18–25.66 1.34 1.06–1.69
Use of fertility preservation 2.84 1.75–4.61 1.12 0.58–2.16
 ≥ 1 child at time of diagnosis 0.54 0.33–0.88 3.1 1.54–6.22
Disease
 Acute leukemia (reference) 1.0 n.a 1.0 n.a
 Multiple myeloma 0.34 0.03–3.95
 Indolent non-Hodgkin lymphoma 0.61 0.22–1.70 5.13 1.06–24.87
 Myeloproliferative neoplasm 0.87 0.48–1.58 0.62 0.17–2.25
 Aggressive non-Hodgkin or Hodgkin’s lymphoma 0.83 0.40–1.72 4.39 1.83–10.58
Therapy
 Chemotherapy/exclusive (reference) 1.0 n.a 1.0 n.a
 Chemotherapy/combined 1.38 0.86–2.22 0.81 0.35–1.89
 Autologous stem cell transplantation 1.53 0.77–3.05 1.52 0.56–4.17
 Allogeneic stem cell transplantation 0.86 0.45–1.63 0.18 0.08–0.41
 Other 1.07 0.59–1.93 0.84 0.32–2.20

CI confidence interval, n.a. not applicable

aPer 5 years